These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9210688)

  • 41. Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.
    Louie A; Banerjee P; Drusano GL; Shayegani M; Miller MH
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2841-7. PubMed ID: 10582869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of GM-CSF and G-CSF on human neutrophil function.
    Bober LA; Grace MJ; Pugliese-Sivo C; Rojas-Triana A; Waters T; Sullivan LM; Narula SK
    Immunopharmacology; 1995 Mar; 29(2):111-9. PubMed ID: 7539779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of severe burn injury on proinflammatory cytokines and leukocyte behavior: its modulation with granulocyte colony-stimulating factor.
    Peter FW; Schuschke DA; Barker JH; Fleishcher-Peter B; Pierangeli S; Vogt PM; Steinau HU
    Burns; 1999 Sep; 25(6):477-86. PubMed ID: 10498354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential phenotype of immune cells in blood and milk following pegylated granulocyte colony-stimulating factor therapy during a chronic Staphylococcus aureus infection in lactating Holsteins.
    Putz EJ; Eder JM; Reinhardt TA; Sacco RE; Casas E; Lippolis JD
    J Dairy Sci; 2019 Oct; 102(10):9268-9284. PubMed ID: 31400902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of neutrophil and monocyte function by microbicidal cell-kill assay in patients with cancer receiving granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or no cytokine after cytotoxic chemotherapy: a phase II trial.
    Nemunaitis J; Cox J; Meyer W; Courtney A; Hanson T; Green-Weaver C; Agosti J
    Am J Clin Oncol; 1998 Jun; 21(3):308-12. PubMed ID: 9626806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of iron on fluconazole activity against Candida albicans in presence of human serum or monocyte-derived macrophages.
    Minn Y; Brummer E; Stevens DA
    Mycopathologia; 1997; 138(1):29-35. PubMed ID: 9404022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
    J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between fluconazole dosage regimens and the emergence of fluconazole-resistant Candida albicans.
    Goetz MB
    AIDS; 1996 Mar; 10(3):335-6. PubMed ID: 8882674
    [No Abstract]   [Full Text] [Related]  

  • 49. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
    Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
    J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of fluconazole and cytokines on human mononuclear cells.
    Fidan I; Yuksel S; Imir T; Kalkanci A; Kustimur S; Ilhan MN
    Mem Inst Oswaldo Cruz; 2007 May; 102(2):127-31. PubMed ID: 17426874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of fluconazole-resistant strains of Candida albicans in otherwise healthy outpatients.
    Haberland-Carrodeguas C; Allen CM; Beck FM; Buesching WJ; Koletar SL; Sundstrom P
    J Oral Pathol Med; 2002 Feb; 31(2):99-105. PubMed ID: 11896831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fungemia in patients with hematologic malignancies: therapeutic effects of concomitant administration of fluconazole and granulocyte-colony-stimulating factor.
    Niitsu N; Umeda M
    Chemotherapy; 1996; 42(3):215-19. PubMed ID: 8983890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infection.
    Ruhnke M; Adler A; Müller FM
    Clin Microbiol Infect; 2000 Apr; 6(4):220-3. PubMed ID: 11168112
    [No Abstract]   [Full Text] [Related]  

  • 54. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    Khan MA; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of cytokines and fluconazole on the activity of human monocytes against Candida albicans.
    Baltch AL; Smith RP; Franke MA; Ritz WJ; Michelsen PB; Bopp LH
    Antimicrob Agents Chemother; 2001 Jan; 45(1):96-104. PubMed ID: 11120951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
    Pancholi P; Park S; Perlin D; Kubin C; Della-Latta P
    J Clin Microbiol; 2004 Dec; 42(12):5938-9. PubMed ID: 15583347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism-based pharmacokinetic-pharmacodynamic models of in vitro fungistatic and fungicidal effects against Candida albicans.
    Venisse N; Grégoire N; Marliat M; Couet W
    Antimicrob Agents Chemother; 2008 Mar; 52(3):937-43. PubMed ID: 18180347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced phagocytosis and intracellular killing of Candida albicans by GM-CSF-activated human neutrophils.
    Richardson MD; Brownlie CE; Shankland GS
    J Med Vet Mycol; 1992; 30(6):433-41. PubMed ID: 1287162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro effects of recombinant human granulocyte-macrophage colony-stimulating factor (RhGM-CSF) on polymorphonuclear cell (PMN) and monocyte (MO) functional capacities in ovarian cancer patients versus human volunteers.
    Altamura M; Geronimo MG; Pepe M; Lella P; Nappi L; Loizzi P; Forte M; Marsilio M; Piazzolla G; Antonaci S; Jirillo E
    Immunopharmacol Immunotoxicol; 1997 Nov; 19(4):437-49. PubMed ID: 9436044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.